Biogerontological Research: Shedding New Light On Old Questions Of Longevity And Prolongevity

The maximum human life span is about 115 years. And that has not changed for millennia. What has changed more recently is our life expectancy. The average person in ancient Greece and Rome could expect to live about 20 years. By 1900, this had increased to nearly 50 years. Today, people in developed nations can expect to live more than 75 years. My interest in this subject goes back more than three decades, when I began a book about it. The term "prolongevity" was coined in 1955 by historian Ger

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

My interest in this subject goes back more than three decades, when I began a book about it. The term "prolongevity" was coined in 1955 by historian Gerald J. Gruman to refer to the significant extension of natural life span by human effort. Unfortunately, the book was sidetracked by another project--founding and growing the Institute for Scientific Information. But my interest in the topic was recently piqued by Leonard Hayflick's excellent book How and Why We Age (New York: Ballantine Books, 1994).

Hayflick overturned the entrenched dogma in cell biology that normal cells can grow indefinitely outside the organism when supplied with necessary nutrients. This cell "immortality" concept was advanced by Alexis Carrel in 1912 and subsequently became a paradigm for the field. It fostered the belief that aging must be an extracellular process. In a classic 1961 paper (Experimental Cell Research, 25:585-621), Hayflick and Paul Moorhead discovered the opposite--that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies